Last reviewed · How we verify
NCT05548192
SmartPICC-1 Feasibility Study Technical Feasibility Study
trial testing SmartPICC-1 System in Catheter Complications in 42 participants. Completed in 23 August 2022.
23 August 2022
Quick facts
| Lead sponsor | Piccolo Medical |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 42 |
| Start date | 1 April 2021 |
| Primary completion | 23 August 2022 |
| Estimated completion | 23 August 2022 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- SmartPICC-1 System
Conditions studied
- Catheter Complications — all drugs for Catheter Complications →
Sponsor
Piccolo Medical
Who can join
Adults 22 to 85, any sex, with Catheter Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this study is to evaluate the safety and technical feasibility of the Piccolo Medical SmartPICC System, indicated for guidance and positioning of commercially available central venous catheters, for PICC placement in adults.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05548192
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Catheter Complications
Currently open trials in the same condition.
- NCT05168943 — Nylon Versus Polyurethane Epidural Catheters In Patients Undergoing Major Orthopedic Surgery · NA · recruiting
- NCT05537389 — Intravenous Neonatal Central Access Safety Trial · NA · recruiting
- NCT05209841 — Heparinization vs Salinization of the Peripheral Venous Catheter · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05548192 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Piccolo Medical
- Last refreshed: 3 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05548192.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing